Litcius/Paper detail

Long-term outcome of “Sandwich” chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive disease

Rahul V. Parghane, Vikas Ostwal, Anant Ramaswamy, Manish Bhandare, Vikram Chaudhari, Sanjay Talole, Shailesh V. Shrikhande, Sandip Basu

2020European Journal of Nuclear Medicine and Molecular Imaging49 citationsDOI

Topics & Concepts

MedicineCommon Terminology Criteria for Adverse EventsInternal medicineRadionuclide therapyResponse Evaluation Criteria in Solid TumorsNeuroendocrine tumorsAdverse effectOncologyProgressive diseaseCapecitabineQuality of life (healthcare)Progression-free survivalTemozolomideCancerChemotherapyColorectal cancerNursingNeuroendocrine Tumor Research AdvancesThyroid Cancer Diagnosis and TreatmentLung Cancer Research Studies
Long-term outcome of “Sandwich” chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive disease | Litcius